Track cost pressure
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
BNF presentation directory
Explore British National Formulary presentations, drill into dispensing trend data, and identify which pharmacies drive the greatest usage of each medicine.
Active filters
- Chemical substance: Pramipexole
| Presentation | Product | Chemical substance | Chapter | Items dispensed |
|---|---|---|---|---|
|
Mirapexin 3.15mg modified-release tablets
0409010W0BBAIAI
|
Mirapexin | Pramipexole | Central Nervous System | 134 |
|
Mirapexin 0.35mg tablets
0409010W0BBADAD
|
Mirapexin | Pramipexole | Central Nervous System | 124 |
|
Mirapexin 0.7mg tablets
0409010W0BBAAAA
|
Mirapexin | Pramipexole | Central Nervous System | 93 |
|
Mirapexin 2.62mg modified-release tablets
0409010W0BBAKAK
|
Mirapexin | Pramipexole | Central Nervous System | 79 |
|
Oprymea 0.088mg tablets
0409010W0BDAAAC
|
Oprymea | Pramipexole | Central Nervous System | 8 |
|
Oprymea 1.05mg modified-release tablets
0409010W0BDAGAG
|
Oprymea | Pramipexole | Central Nervous System | 6 |
|
Oprymea 0.26mg modified-release tablets
0409010W0BDAEAE
|
Oprymea | Pramipexole | Central Nervous System | 3 |
|
Oprymea 1.57mg modified-release tablets
0409010W0BDAHAJ
|
Oprymea | Pramipexole | Central Nervous System | 2 |
|
Oprymea 2.1mg modified-release tablets
0409010W0BDAIAH
|
Oprymea | Pramipexole | Central Nervous System | 2 |
|
Neliprax 0.088mg tablets
0409010W0BCAAAC
|
Neliprax | Pramipexole | Central Nervous System | No data available |
|
Neliprax 0.18mg tablets
0409010W0BCABAB
|
Neliprax | Pramipexole | Central Nervous System | No data available |
|
Neliprax 0.35mg tablets
0409010W0BCADAD
|
Neliprax | Pramipexole | Central Nervous System | No data available |
|
Neliprax 0.7mg tablets
0409010W0BCACAA
|
Neliprax | Pramipexole | Central Nervous System | No data available |
|
Oprymea 0.18mg tablets
0409010W0BDABAB
|
Oprymea | Pramipexole | Central Nervous System | No data available |
|
Oprymea 0.35mg tablets
0409010W0BDACAD
|
Oprymea | Pramipexole | Central Nervous System | No data available |
|
Oprymea 0.52mg modified-release tablets
0409010W0BDAFAF
|
Oprymea | Pramipexole | Central Nervous System | No data available |
|
Oprymea 0.7mg tablets
0409010W0BDADAA
|
Oprymea | Pramipexole | Central Nervous System | No data available |
|
Oprymea 2.62mg modified-release tablets
0409010W0BDAJAK
|
Oprymea | Pramipexole | Central Nervous System | No data available |
|
Oprymea 3.15mg modified-release tablets
0409010W0BDAKAI
|
Oprymea | Pramipexole | Central Nervous System | No data available |
Why monitor BNF codes?
Link medicine usage to pharmacy and prescriber behaviour to find optimisation opportunities.
Understand demand drivers
Cross-reference high-volume medicines with local health priorities and prescriber activity to target support programs.